Date published: 2026-4-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

MCM5 Inhibitors

Minichromosome Maintenance Complex Component 5 (MCM5) is a crucial protein within the MCM complex, which plays a pivotal role in the initiation and elongation phases of DNA replication. The MCM complex, consisting of six homologous subunits (MCM2-7), functions as a helicase, unwinding the DNA helix to allow replication machinery to synthesize new DNA strands. MCM5, in particular, is essential for the formation and activation of the pre-replication complex (pre-RC), marking origins of replication before the S phase of the cell cycle, and ensuring that DNA replication is initiated accurately and efficiently once per cycle. The regulation of MCM5 and its activity is tightly controlled, as it is integral to maintaining genomic stability and preventing DNA damage or replication stress, which could lead to genomic instability or cell cycle arrest. The inhibition of MCM5 involves mechanisms that disrupt its normal function in DNA replication, either by direct interaction with MCM5 itself or by affecting the regulatory pathways that control the MCM complex's assembly, activation, or function. Direct inhibition can be achieved by molecules that bind to MCM5, obstructing its interaction with other MCM subunits or with DNA, thereby preventing the helicase activity required for DNA unwinding. Indirect inhibition strategies may target signaling pathways that regulate the activation of the MCM complex, such as those involving kinases that phosphorylate MCM proteins, including MCM5, which is necessary for their activation at the onset of S phase. Additionally, the alteration of protein-protein interactions essential for the assembly of the MCM complex or the modification of the cellular environment to affect MCM5's stability or localization can also effectively inhibit its function. Understanding the intricate mechanisms of MCM5 inhibition sheds light on potential strategies to control DNA replication processes, with implications for studying cell cycle regulation, genomic stability, and the cellular response to DNA damage.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

BAY 869766

923032-37-5sc-364427
sc-364427A
5 mg
10 mg
$245.00
$428.00
1
(1)

BAY 869766 inhibits MCM5 by directly targeting the protein's ATPase activity, crucial for its function in DNA replication initiation. This inhibition disrupts the unwinding of DNA, essential for replication, leading to the stalling of DNA synthesis. The specific mechanism involves competitive binding to the ATP-binding site, preventing ATP hydrolysis.

MEK 162

606143-89-9sc-488879
10 mg
$306.00
(0)

MEK162 (Binimetinib) achieves inhibition of MCM5 indirectly through the blockade of MEK, which is upstream of key regulatory pathways controlling MCM5 phosphorylation and activation. This interference prevents the necessary activation signals from reaching MCM5, impairing its ability to initiate DNA replication.

Cobimetinib

934660-93-2sc-507421
5 mg
$270.00
(0)

GDC-0973 (Cobimetinib) inhibits MCM5 by targeting the MEK/ERK signaling pathway, which plays a critical role in the phosphorylation and subsequent activation of MCM5. The inhibition of this pathway leads to a decrease in MCM5 activity, effectively blocking the progression of DNA replication.

AS703026

1236699-92-5sc-364412
sc-364412A
5 mg
10 mg
$80.00
$130.00
(0)

AS703026 inhibits MCM5 indirectly by suppressing the activity of MEK, which is involved in the phosphorylation-based activation of MCM5 essential for the commencement of DNA replication. This suppression results in the reduced phosphorylation of MCM5, diminishing its replication initiation capability.